Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
European Journal of Medicinal Chemistry|February 7, 2025
Different chemical scaffolds bind to L-phe site in Mycobacterium tuberculosis Phe-tRNA synthetasePriyanka Gade, Changsoo Chang, Denise S Pryde, et al.Journal of Medicinal Chemistry|April 15, 2005
Potent and selective Aurora inhibitors identified by the expansion of a novel scaffold for protein kinase inhibitionDaniele Fancelli, Daniela Berta, Simona Bindi, et al.Microbiology Spectrum|May 9, 2023
Susceptibility of Ugandan Plasmodium falciparum Isolates to the Antimalarial Drug PipelineOriana Kreutzfeld, Patrick K Tumwebaze, Martin Okitwi, et al.Journal of Medicinal Chemistry|January 19, 2008
Cdc7 kinase inhibitors: pyrrolopyridinones as potential antitumor agents. 1. Synthesis and structure-activity relationshipsErmes Vanotti, Raffaella Amici, Alberto Bargiotti, et al.Journal of Medicinal Chemistry|November 28, 2006
1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazoles: identification of a potent Aurora kinase inhibitor with a favorable antitumor kinase inhibition profileDaniele Fancelli, Jürgen Moll, Mario Varasi, et al.ACS Infectious Diseases|September 15, 2021
Prioritization of Molecular Targets for Antimalarial Drug DiscoveryBarbara Forte, Sabine Ottilie, Andrew Plater, et al.Bioorganic & Medicinal Chemistry|September 7, 2010
Thieno[3,2-c]pyrazoles: a novel class of Aurora inhibitors with favorable antitumor activitySimona Bindi, Daniele Fancelli, Cristina Alli, et al.Journal of Medicinal Chemistry|November 10, 2023
Identification and Optimization of Novel Inhibitors of the Polyketide Synthase 13 Thioesterase Domain with Antitubercular ActivitySimon R Green, Caroline Wilson, Thomas C Eadsforth, et al.Journal of Medicinal Chemistry|July 30, 2015
Discovery of 2-[1-(4,4-Difluorocyclohexyl)piperidin-4-yl]-6-fluoro-3-oxo-2,3-dihydro-1H-isoindole-4-carboxamide (NMS-P118): A Potent, Orally Available, and Highly Selective PARP-1 Inhibitor for Cancer TherapyGianluca Papeo, Helena Posteri, Daniela Borghi, et al.Journal of Medicinal Chemistry|January 1, 2009
First Cdc7 kinase inhibitors: pyrrolopyridinones as potent and orally active antitumor agents. 2. Lead discoveryMaria Menichincheri, Alberto Bargiotti, Jens Berthelsen, et al.Pageof 3